UNSPSC 51203903: Sodium aurothiomalate

This classification denotes a protein kinase c inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) E4768ZY6GM. European Medicines Agency schedules Sodium aurothiomalate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10550MIG. Sodium aurothiomalate generally arises in the molecular formula C4H6O4SXNA. The term SODIUM AUROTHIOMALATE is a European Pharmacopoeia designation. Most nations, for tariff and trade purposes, schedule sodium aurothiomalate under HS 28433000 and SITC 52432.

SMILES: C(C(C(=O)[O-])[S-])C(=O)[O-].[Na+].[Na+].[Au+].

UNSPSC 51203903 Sodium aurothiomalate, a Commodity code, shows minimal recent state and local procurement activity directly aligned with the code's pharmaceutical scope. The recent opportunities tagged to this code involve naloxone kits, medical and first aid supplies for emergency response, generic pharmaceuticals through cooperative purchasing, and pharmacy benefit program design—none of which are sodium aurothiomalate or closely related products. The code appears to reflect a narrow pharmaceutical ingredient or injectable medication, but the state and local solicitations posted under it do not target that specific product line.

The four recent opportunities span different jurisdictions and procurement vehicles: Seminole County, Florida (IFB for naloxone and drug deactivation systems, due July 26, 2023); Texas Health and Human Services Commission (RFI for direct-to-manufacturer pharmacy programs, response due April 3, 2026); City of Tampa (IFB for medical and first aid supplies for the Fire Department Rescue Division, due March 13, 2026, estimated contract value $700,000 with a 5% SLBE bid discount capped at $10,000); and Minnesota Multistate Cooperative Purchasing Alliance (RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, through authorized wholesalers AmerisourceBergen, Cardinal Health, and Morris & Dickson). The geographic spread includes Florida, Texas, Minnesota, and Oregon through the cooperative purchasing vehicle. The mismatch between the code's specific pharmaceutical designation and the actual work solicited—broad medical supplies, naloxone programs, and generic pharmaceutical contracting—suggests either a misclassification in the source data or limited current demand for sodium aurothiomalate specifically within state and local procurement channels.